)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Eevia Health
Eevia Health (EEVIA) investor relations material
Eevia Health has been delisted
Eevia Health Q1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2025 earnings summary20 May, 2025
Executive summary
Net sales in Q1 2025 rose 78% sequentially to KEUR 467, but declined 30% year-over-year due to prior periodization effects; underlying sales trend is positive over six quarters.
Strategic pivot to high-strength, proprietary extracts is gaining traction, with new long-term sales partnerships and increased interest from major global brands.
Cost-cutting and organizational restructuring continued, with reduced personnel and operating expenses.
Financial highlights
Gross profit in Q1 2025 was KEUR 276, up 87% from Q4 2024, but down 26% from Q1 2024; gross margin improved to 59% from 37% sequentially.
EBITDA was KEUR -166 in Q1 2025, compared to KEUR -103 in Q1 2024; Q4 2024 EBITDA was positive due to one-time items.
Net result after tax was KEUR -499 in Q1 2025, versus KEUR -387 in Q1 2024 and KEUR 119 in Q4 2024.
Cash flow from operations was negative KEUR -434, compared to KEUR 4 in Q4 2024 and KEUR -253 in Q1 2024.
Earnings per share for Q1 2025 was EUR -0.004, with shareholders' equity per share at EUR 0.02.
Outlook and guidance
Management expects strong revenue growth in H2 2025 and 2026, targeting quarterly revenue of KEUR 900 and annual revenue of MEUR 3.6 for profitability.
Short-term focus is on maintaining gross margin near 60%, further cost reductions, and leveraging new sales contracts.
Achieving growth depends on successful private placement, national funding, and inventory reduction to free up cash.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Eevia Health
- Turnaround plan launched after Q3-24 net loss of KEUR -931 and 52% sales decline year-over-year.EEVIA
Q3 2024 - Net sales fell 79% year-over-year, but gross margin rose to 76% on improved product mix.EEVIAQ2 2024
- Pivoting to gut health, branded products, and cost efficiency to drive future growth and value.EEVIAStatus Update
- Strategic pivot to science-backed gut health, divestments, and cost focus to drive future growth.EEVIAStatus Update
- Accelerated focus on science-backed health solutions, divestments, and a SEK 12M rights issue.EEVIAStatus Update
- Restructuring into three focused units aims to drive growth and stabilize finances.EEVIAStatus Update
- Revenue dropped sharply in 2024; turnaround and new funding are critical for recovery.EEVIAQ4 2024
Eevia Health
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Eevia Health Plc is a Finland-based company specializing in the production of organic plant-based health ingredients. The company focuses on sustainable sourcing and manufacturing of bioactive compounds derived from arctic plant materials, such as berries and herbs. Its products are primarily used in dietary supplements, functional foods, and cosmetics, supporting wellness and health-focused markets. The company is headquartered in Seinäjoki, Finland, and its shares are listed on the Nasdaq First North Growth Market.